BackgroundLoss to follow-up (LTFU) is a term used to classify patients no longer being seen in a clinical care program, including HIV treatment programs. It is unclear if these patients have transferred their care services elsewhere, died, or if there are other reasons for their LTFU. To better understand the status of patients meeting the criteria of LTFU, we traced a sample of HIV-infected patients that were LTFU from the Lagos University Teaching Hospital (LUTH) antiretroviral program.MethodsWe conducted a cross-sectional study of HIV-infected adult patients who enrolled for care between 2010 and 2014 at LUTH and were considered LTFU. Patients with locator information were traced using phone calls. Face-to-face interviews were used to co...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
It is known that ‘drop out’ from human immunodeficiency virus (HIV) treatment, the so called lost-...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
BackgroundA better understanding why people living with HIV (PLHIV) become lost to follow-up (LTFU) ...
OBJECTIVES: To understand reasons for lost to follow-up (LTFU) from a community-based antiretroviral...
Background: Considerable success has been recorded in the global fight against the human immunodefic...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
BHIVA guidelines recommend that all ARV-naïve and stable on-treatment patients are monitored at leas...
INTRODUCTION:Improved HIV outcomes as a result of expanded antiretroviral therapy (ART) access is th...
Current estimates of retention among HIV-infected patients on antiretroviral therapy (ART) in Africa...
<div><p>Introduction</p><p>Improved HIV outcomes as a result of expanded antiretroviral therapy (ART...
BackgroundAlthough patient attrition is recognized as a threat to the long-term success of antiretro...
Introduction: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose c...
Many HIV treatment programs in resource-limited settings are plagued by high rates of loss to follow...
BACKGROUND:Retaining patients starting antiretroviral therapy (ART) and ensuring good adherence rema...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
It is known that ‘drop out’ from human immunodeficiency virus (HIV) treatment, the so called lost-...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
BackgroundA better understanding why people living with HIV (PLHIV) become lost to follow-up (LTFU) ...
OBJECTIVES: To understand reasons for lost to follow-up (LTFU) from a community-based antiretroviral...
Background: Considerable success has been recorded in the global fight against the human immunodefic...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
BHIVA guidelines recommend that all ARV-naïve and stable on-treatment patients are monitored at leas...
INTRODUCTION:Improved HIV outcomes as a result of expanded antiretroviral therapy (ART) access is th...
Current estimates of retention among HIV-infected patients on antiretroviral therapy (ART) in Africa...
<div><p>Introduction</p><p>Improved HIV outcomes as a result of expanded antiretroviral therapy (ART...
BackgroundAlthough patient attrition is recognized as a threat to the long-term success of antiretro...
Introduction: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose c...
Many HIV treatment programs in resource-limited settings are plagued by high rates of loss to follow...
BACKGROUND:Retaining patients starting antiretroviral therapy (ART) and ensuring good adherence rema...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
It is known that ‘drop out’ from human immunodeficiency virus (HIV) treatment, the so called lost-...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...